Autologous bone marrow mononuclear cells: Phase II data

Researchers at the hospital and colleagues reported data from the double-blind, U.S. Phase II Late TIME trial in 87 patients with

Read the full 219 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE